Michael Lane sold $5.3M of IDXX
Executive Vice President at IDEXX LABORATORIES INC /DE. 8,411 shares at an average of $627.74, traded Aug 6, 2025, filed Aug 8, 2025.
Score components
- +15RoleOfficer
- +25Trade size$5.3M at market
- +20Share of holdings soldSold 54% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874716-25-000125, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 6, 2025 | MOption exercise Common Stock | +1,286 | $206.94 | $266k | 8,418 | Aug 8, 2025 |
| Aug 6, 2025 | MOption exercise Common Stock | +7,125 | $288.78 | $2.1M | 15,543 | Aug 8, 2025 |
| Aug 6, 2025 | SOpen-market sale Common Stock | -5,631 | $627.56 | $3.5M | 9,912 | Aug 8, 2025 |
| Aug 6, 2025 | SOpen-market sale Common Stock | -2,480 | $627.99 | $1.6M | 7,432 | Aug 8, 2025 |
| Aug 6, 2025 | SOpen-market sale Common Stock | -300 | $628.89 | $189k | 7,132 | Aug 8, 2025 |
| Aug 6, 2025 | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -1,286 | $0.00 | $0 | 0 | Aug 8, 2025 |
| Aug 6, 2025 | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -7,125 | $0.00 | $0 | 0 | Aug 8, 2025 |
Related signals
Other insiders at IDEXX LABORATORIES INC /DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | IDXXsell IDEXX LABORATORIES INC /DE | Lawrence D Kingsley director | $1.2M 2,203 shares | -19% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $1.1M 1,758 shares | -9% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Jonathan Jay Mazelsky President and CEO | $15M 23,326 shares | -22% | |
| 60Notable | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $1.8M 2,693 shares | -12% | |
| 50Moderate | IDEXX LABORATORIES INC /DE | Michael G Erickson Executive Vice President | $3.4M 5,371 shares | -30% | |
| 59Moderate | IDEXX LABORATORIES INC /DE | Sophie V. Vandebroek director | $920k 1,464 shares | -69% | |
| 60Notable | IDEXX LABORATORIES INC /DE | George Fennell Executive Vice President | $7.3M 11,345 shares | -54% | |
| 35Weak | IDXXsell IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $6.6M 9,425 shares | -31% | |
| 60Notable | IDEXX LABORATORIES INC /DE | M Anne Szostak director | $1.4M 2,187 shares | -89% | |
| 43Moderate | IDEXX LABORATORIES INC /DE | Michael G Erickson Executive Vice President | $264k 406 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.